Position in AMGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,886,820
+$720,480 QoQ
Shares Held
7,972
+29.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,094
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pure Financial Advisors, LLC holds $38,114,911 across 13 Drug Manufacturers - General names. AMGN ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,010 | $8,408,005 | |
| 2 | MRK |
Merck & Co., Inc.
|
59,640 | $7,663,740 | |
| 3 | JNJ |
Johnson & Johnson
|
29,199 | $7,415,670 | |
| 4 | ABBV |
AbbVie Inc.
|
23,887 | $6,010,924 | |
| 5 | AMGN |
Amgen Inc
This page
|
7,972 | $2,886,820 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,483 | $1,295,470 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,775 | $982,293 | |
| 8 | NVO |
Novo Nordisk A S
|
16,779 | $804,385 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,886,820 | 7,972 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $2,166,340 | 6,157 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,803,150 | 5,509 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $1,273,004 | 4,511 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,346,350 | 4,822 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,299,163 | 4,170 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $913,021 | 3,503 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,082,947 | 3,361 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,057,955 | 3,386 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $808,037 | 2,842 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $747,987 | 2,597 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $669,481 | 2,491 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $454,918 | 2,049 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $490,027 | 2,027 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $512,935 | 1,953 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $426,006 | 1,890 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $447,672 | 1,840 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $394,166 | 1,630 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $418,669 | 1,861 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $368,097 | 1,731 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $419,006 | 1,719 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $424,469 | 1,706 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $337,752 | 1,469 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $373,361 | 1,469 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $346,478 | 1,469 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $289,701 | 1,429 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||